CME Group (NASDAQ:CME) Rating Increased to Strong-Buy at Erste Group Bank

CME Group (NASDAQ:CMEGet Free Report) was upgraded by stock analysts at Erste Group Bank to a “strong-buy” rating in a report released on Monday,Zacks.com reports.

Other research analysts also recently issued research reports about the stock. Royal Bank of Canada raised their target price on shares of CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research report on Thursday, February 13th. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research report on Friday, February 14th. Morgan Stanley raised their target price on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 19th. Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and lowered their price target for the company from $255.00 to $250.00 in a report on Monday, January 6th. Finally, Barclays raised their price target on shares of CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $238.93.

Read Our Latest Analysis on CME Group

CME Group Trading Up 1.1 %

CME stock opened at $266.49 on Monday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The company has a market capitalization of $96.03 billion, a PE ratio of 27.56, a P/E/G ratio of 6.76 and a beta of 0.53. The firm’s 50-day moving average is $244.35 and its 200 day moving average is $233.28. CME Group has a 12 month low of $190.70 and a 12 month high of $266.93.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, research analysts anticipate that CME Group will post 10.49 EPS for the current year.

CME Group announced that its board has approved a stock repurchase plan on Thursday, December 5th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.

Insider Activity

In related news, insider Hilda Harris Piell sold 3,984 shares of the business’s stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the completion of the transaction, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. The trade was a 12.84 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock valued at $6,871,496 in the last ninety days. Insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

Large investors have recently made changes to their positions in the company. SJS Investment Consulting Inc. raised its position in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares during the period. Truvestments Capital LLC acquired a new position in CME Group during the third quarter worth $26,000. Dunhill Financial LLC raised its position in CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares during the period. New Age Alpha Advisors LLC raised its position in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 43 shares during the period. Finally, Financial Life Planners acquired a new position in CME Group during the fourth quarter worth $32,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.